Canadian retailer Kits Eyecare misses Q3 sales estimates

Kits Eyecare

07/10/2025 12:17

Overview

Kits Eyecare Q3 revenue up 25.1% yr/yr to C$52.4 mln, missing estimates

Adjusted EBITDA for Q3 increased to approximately 5.2% of revenue

New customers grew 27.6% yr/yr to about 99,000

Outlook

Company did not provide specific guidance for future quarters or year

Result Drivers

CUSTOMER GROWTH - New customers increased by 27.6% year-over-year to approximately 99,000, contributing to revenue growth

OPERATIONAL CHALLENGES - Company navigated complexities including border changes and postal strikes, maintaining strong cash position

REVENUE - Total revenue grew 25.1% year-over-year to approximately C$52.4 million

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
C$52.40 mln
C$53.10 mln (5 Analysts)

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy"

Wall Street's median 12-month price target for Kits Eyecare Ltd is C$23.00, about 20.8% above its October 6 closing price of C$18.21

The stock recently traded at 69 times the next 12-month earnings vs. a P/E of 67 three months ago

Press Release: ID:nCNW5sNHda

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)